Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine

Dermatology : International Journal for Clinical and Investigative Dermatology
M CorazzaA Virgili

Abstract

We report the case of a 61-year-old woman who developed an anaplastic CD30+ cutaneous T-cell lymphoma during oral cyclosporine (CsA) therapy for recalcitrant psoriasis. Two months after CsA discontinuation, clinical and histological resolution of the lymphoma was observed. However, 3 years later extracutaneous involvement of the lymphoma could be detected. The association between CsA administration and the occurrence of the lymphoma may be casual, but a relationship with immunosuppression may also be hypothesized. We have reviewed all relevant data in the literature. To our knowledge, this is the first case of primary cutaneous CD30+ anaplastic large T-cell lymphoma in a patient treated with CsA for psoriasis.

Citations

Jul 3, 2010·Expert Review of Clinical Immunology·Meenakshi Bewtra, James D Lewis
Apr 5, 2011·Journal of the American Academy of Dermatology·Yi-Ju ChenYun-Ting Chang
Nov 26, 2010·Journal of the American Academy of Dermatology·Caitriona RyanAlan Menter
May 1, 2009·La Revue de médecine interne·K JaberN Doss
Apr 7, 2009·Journal of the American Academy of Dermatology·Rita V PatelJeffrey M Weinberg
Jun 14, 2005·The British Journal of Dermatology·S LaubeB B Tan
Apr 24, 2007·Journal of the European Academy of Dermatology and Venereology : JEADV·J SchmittM Meurer
Jan 17, 2007·The British Journal of Dermatology·J CallenB U Wintroub
Sep 29, 2004·Dermatologic Clinics·David S Aaronson, Mark Lebwohl
Mar 8, 2006·Archives of Pathology & Laboratory Medicine·You-Wen QianPritish Bhattacharyya

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

© 2022 Meta ULC. All rights reserved